- Home
- PLBC vs AQST Comparison
PLBC vs AQST Comparison
Compare PLBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- AQST
- Stock Information
- Founded
- PLBC 1980
- AQST 2004
- Country
- PLBC United States
- AQST United States
- Employees
- PLBC N/A
- AQST N/A
- Industry
- PLBC Finance Companies
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PLBC Finance
- AQST Health Care
- Exchange
- PLBC Nasdaq
- AQST Nasdaq
- Market Cap
- PLBC 236.7M
- AQST 272.9M
- IPO Year
- PLBC 2005
- AQST 2018
- Fundamental
- Price
- PLBC $47.50
- AQST $3.74
- Analyst Decision
- PLBC Buy
- AQST Strong Buy
- Analyst Count
- PLBC 3
- AQST 6
- Target Price
- PLBC $57.67
- AQST $10.67
- AVG Volume (30 Days)
- PLBC 14.6K
- AQST 1.5M
- Earning Date
- PLBC 07-16-2025
- AQST 08-05-2025
- Dividend Yield
- PLBC 2.53%
- AQST N/A
- EPS Growth
- PLBC 3.33
- AQST N/A
- EPS
- PLBC 4.95
- AQST N/A
- Revenue
- PLBC $84,001,000.00
- AQST $54,228,000.00
- Revenue This Year
- PLBC $19.95
- AQST N/A
- Revenue Next Year
- PLBC $22.19
- AQST $45.71
- P/E Ratio
- PLBC $9.60
- AQST N/A
- Revenue Growth
- PLBC 9.14
- AQST 5.29
- 52 Week Low
- PLBC $33.26
- AQST $2.12
- 52 Week High
- PLBC $51.33
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- PLBC 69.14
- AQST 68.54
- Support Level
- PLBC $41.21
- AQST $3.13
- Resistance Level
- PLBC $49.47
- AQST $3.33
- Average True Range (ATR)
- PLBC 1.44
- AQST 0.22
- MACD
- PLBC 0.56
- AQST 0.01
- Stochastic Oscillator
- PLBC 76.15
- AQST 94.10
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.